摘要
Chemoresistance constitute nowadays the major contributor to therapy failure in most cancers.There are main factors that mitigate cell response to therapy,such as target organ,inherent sensitivity to the administered compound,its metabolism,drug efflux and influx or alterations on specific cellular targets,among others.We now know that intrinsic properties of cancer cells,including metabolic features,substantially contribute to chemoresistance.In fact,during the last years,numerous reports indicate that cancer cells resistant to chemotherapy demonstrate significant alterations in mitochondrial metabolism,membrane polarization and mass.Metabolic activity and expression of several mitochondrial proteins are modulated under treatment to cope with stress,making these organelles central players in the development of resistance to therapies.Here,we review the role of mitochondria in chemoresistant cells in terms of metabolic rewiring and function of key mitochondria-related proteins.
基金
This work was supported by the Miguel Servet Program(CP16/00121)and a FIS(Fondo Investigaciones Sanitarias)grant(PI17/00082)
both from the Instituto de Salud Carlos III and cofinanced by European funds(FSE:“el FSE invierte en tu futuro”and FEDER:“una manera de hacer Europa,”respectively).